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Zhigang Zhang2, Jianwei Wang1, Jian Huang1,2* and Xiuyan Yu1*Abstract
Background: Umbilical metastasis, also called Sister Mary Joseph’s nodule (SMJN), is defined as the umbilical
nodule associated with advanced metastatic intra-abdominal and pelvic malignancies. A patient with umbilical
metastasis has been deemed to have a poor prognosis. Rectal cancer presenting with a SMJN is a rare
phenomenon, especially in the early stage and in middle-low rectal cancer.
Case presentation: We report a case of a 70-year-old male presenting with umbilical metastasis derived from
rectal cancer (10 cm from the anal verge, T2N0).
Discussion and conclusion: For rectal cancer with umbilical metastasis, the exact metastatic routes as well as
the criterion of diagnosis and treatments are not very clear. Here we review the literature on rectal cancer and
SMJN to deepen the understanding of this disease.
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Umbilical metastasis, also called Sister Mary Joseph’s
nodule (SMJN), is mostly associated with advanced
metastatic intra-abdominal and pelvic malignancies [1].
In recent years, there are some sporadic reports of
umbilical metastasis. Admittedly, umbilical metastasis
implies a poor prognosis but, so far, the primary tumor
diagnosis, metastasis pathway and treatment of umbilical
metastases are still unclear. Rectal cancer always can be
found an abnormal metastasis, like umbilical metastasis
[2]. Here, we report a rare case of a rectal cancer with
umbilicus metastases and also conduct a substantial review
of the literature relevant to umbilicus metastases from
colorectal cancer.
Case presentation
In October 2012, a 70-year-old male was admitted to
our department complaining of a 5-month history of
abdominal pain, weight loss and constipation. Physical* Correspondence: drhuangjian@zju.edu.cn; yuxiuyan821@hotmail.com
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unless otherwise stated.examination revealed a hard, craggy, painful, subcutaneous
lump, measuring 4.0 × 4.0 cm in the umbilical area of the
abdomen. His blood tests are normal except for a markedly
elevated carcinoembryonic antigen level (5.4 ng/ml). Epi-
gastrium computed tomography scan showed an ill-
defined mass measuring 3.0 × 4.0 cm in diameter in the
umbilical area (Figure 1). Core needle biopsy demonstrated
a moderately differentiated adenocarcinoma (Figure 2).
Pelvic enhanced magnetic resonance imaging revealed
anterior rectal wall irregular thickening, gut cavity stenosis,
and bowel lesions measuring about 40 mm, with the
lesions about 86 mm from the lower edge of the anus
(strenghtened on enhanced scanning; Figure 3). Total
colonoscopy demonstrated adenocarcinoma of the rectum
at 10 cm from the anal verge (Figure 4). Rectal endoscopic
ultrasound showed this rectal tumor infiltrating the mus-
cularis propria (Figure 5); according to TNM classification
this is a stage I (T2N0) rectal cancer. The patient also
underwent a gastroscope (Figure 6) and a chest computedLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Epigastrium computed tomography: an ill-defined
mass at the umbilical area shown by the red arrow.
Figure 3 Pelvic enhanced magnetic resonance imaging: a rectal
lesion at a distance from the anus of about 86 mm (red arrow).
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nosis was rectal carcinoma with umbilical metastasis. After
discussion, our mutidisciplinary team considered that this
patient should accept surgery and subsequent systemic
chemotherapy. The patient refused further treatment and
discharged himself from the hospital.
Discussion
Rectal cancer is one of the most common malignancies
around the world, and has an improved prognosis due
to the development of diagnostic and therapeutic proce-
dures [3]. However, the survival time could be seriously
shortened when distant metastasis occurs. The common
distant metastatic sites of rectal cancer are the liver and
lung. There are also some sporadic reports showing the
spleen, thyroid gland, stomach, pancreas, urinary system
and abdominal wall as sites of possible distant metastasis
[4]. Though the exact metastasis pathway is not very
clear, some potential routes may contribute to it. First,Figure 2 Core needle biopsy of the umbilical mass: a moderately diff
biopsy; B: Pathological diagnosis for the mass.surgery and trauma increase the release of tumor cells
into the circulation, and tissue injury has also been
documented to promote the growth of implanted tumor
cells; these two factors eventually lead to abnormal
tumor metastases. A patient with this metastatic pattern
usually has a surgical trauma history. Secondly, lymph-
atic spread is not only towards the adjacent lymph nodes
but follows a more diffuse pattern, as the lymph nodes
connect to each other. In addition to the lymphatic pipe
outside, some other pipes can also can cause tumor
metastasis. Thirdly, tumor cells in the blood flow
may implant and grow in any proper “soil”. This
hematogenous metastatic pattern often involves mul-
tiple organs and tissues. Direct extension along the
ligaments of embryonic origin, such as the vitellineerentiated adenocarcinoma. A: Ultrasound-guided core needle
Figure 4 Colonoscopy and histopathology examination:
adenocarcinoma of the rectum at 10 cm from the anal verge.
Figure 6 Gastroscope and histopathology examination: a
negative result.
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ment, is another possible route of metastatic spread.
As in our case, rectal cancer with umbilicus metastases
may spread through the urachus.
Umbilical metastasis is also called SMJN, which is
defined as a firm umbilical nodule associated with
advanced metastatic intra-abdominal and pelvic malig-
nancies. In 1949, Sir Hamilton Bailey first used the name
SMJN to describe this umbilical metastatic nodule (in
honor of Sister Mary Joseph Dempsey who found the
association between umbilical nodules and intra-abdom-
inal malignancy) [1]. Through a review of previous case
reports, we found that SMJN arises most frequently from
carcinomas of the stomach or ovary, but has also been
described with carcinomas of the colon, pancreas, small
bowel, gallbladder, lung, prostate, cervix, uterus, fallopianFigure 5 Colonoscopy and rectal endoscopic ultrasound: rectal tumor
colonoscopy; B: Rectal endoscopic ultrasound.tube, myeloma and mesothelioma [5] (Table 1). Different
cancer metastasis to the umbilicus may occur through
different routes, which may include the direct extension,
lymphatic spread, and tumor implantation.
SMJN sometimes may be the only symptom present
in patients with internal malignancies, and may repre-
sent as a late finding in patients with widespread
metastases; it not only indicates malignancy but may
also indicate poor prognosis. The umbilicus metasta-
ses usually occur as the first signal of advanced intra-
abdominal malignancy; however, with a lack of under-
standing, it could be easily mistaken for omphalitis,
cyst, hernia and skin disease, which leads to the
delayed fiding of primary tumors. This could partly
explain why umbilical metastasis patients have a poor
prognosis. SMJN should be kept in mind when meet-
ing a patient with an umbilical nodule. Fine needle
aspiration cytology (FNAC) could be the best alterna-
tive for diagnosis of umbilical nodules, as it has been
proved a simple, inexpensive, and reliable techniqueinfiltrating the muscularispropria (T2N0). A: Image under
Table 1 Primary site of umbilical metastasis (407 + 58
patients)
Primary site n (%)
Stomach 101 (17.9)
Ovary 77 (13.6)




















Unknown or others 64 (11.3)
Modified and updated from [5].
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ments for SMJN should be based on the primary
tumor and the patient’s condition. We suggest surgery
and systemic chemotherapy, but before surgery we
need laparoscopic exploration to estimate the local
tumor and abdominal wall, thereby increasing the diagno-
sis rate and decreasing the rate of the unnecessary “switch
operation”.
Conclusion
Anomalous metastasis is not rare in some malignan-
cies, such as colorectal cancer. Umbilical metastasis
from gastrointestinal adenocarcinoma has been re-
ported in many cases, but it is very rare for middle-
low rectal cancer. Our report described a case of
umbilical metastasis from the early stage rectal cancer
(10 cm from the anal verge, T2N0), and we felt regret
that the patient did not accept our treatment recom-
mendations. The differential diagnosis of an umbilical
lesion should always include metastatic disease apart
from benign lesions and primary neoplasms, andFNAC could give us great help to diagnose the le-
sion. Surgical treatment in umbilical metastasis from
gastrointestinal adenocarcinoma is still controversial, but
we suggest that surgery and systemic chemotherapy are
both necessary for the treatment. Bear in mind that,
before surgery, laparoscopic exploration can avoid un-
necessary damage.
Consent
Written informed consent for publication of this case
report and the associated images were obtained from the
patient.
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